Health F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy. August 26, 2026 Read More → Post navigation Previous: Miley Cyrus Mourns Her Godmother Dolly Parton: ‘I Have an Angel by My Side’Next: Apple Maps has ads now Related Stories Health New mums ‘left to get on with it’ as C-section numbers hit record high September 8, 2026 Health Helping stoma bag users to swim with confidence September 5, 2026 Health How the hunger for a new weight loss drug is feeding an industry of fakes September 4, 2026
